MiR-381 is downregulated in triple-negative breast cancer, which is negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. Here, ERBB2 is linked to triple-negative breast carcinoma.